Weekly paclitaxel: an effective and well-tolerated treatment in patients with advanced breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Weekly paclitaxel: an effective and well-tolerated treatment in patients with advanced breast cancer

Published:2002-12 Issue: Volume:44 Page:15-30
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Lück Hans-Joachim,Roché Henri

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference92 articles.

1. Cancer statistics, 2001;Greenlee;CA Cancer J. Clin.,2001

2. Treatment of metastatic breast cancer;Ellis,2000

3. Paclitaxel in breast cancer;Perez;Oncologist,1998

4. 3-hour (hr) high dose Taxol (T) infusion in advanced breast cancer (ABC): an NSABP phase II study;Mamounas;Proc. Am. Soc. Clin. Oncol.,1995

5. Phase II trial of paclitaxel by 3-hour infusion as initial and salvage chemotherapy for metastatic breast cancer;Seidman;J. Clin. Oncol.,1995

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Re-positioning of low dose paclitaxel against depressive-like behavior and neuroinflammation induced by lipopolysaccharide in rats: Crosstalk between NLRP3/caspase-1/IL-1β and Sphk1/S1P/ NF-κB signaling pathways;Toxicology and Applied Pharmacology;2024-09

2. Dose-Dense Docetaxel-Cyclophosphamide and Epirubicin-Cisplatin(ddDCEP): Analysis of an Alternative Platinum-Containing Regimen in 116 Patients with Early Triple Negative Breast Cancer;Cancer Investigation;2023-10-21

3. The First Evaluation of Serum Levels of MGP, Gas6 and EGFR after First Dose of Chemotherapy in Lung Cancer;Biology;2022-01-06

4. Natural Products in the “Marketplace”: Interfacing Synthesis and Biology;Journal of the American Chemical Society;2019-01-25

5. Alisertib in Combination With Weekly Paclitaxel in Patients With Advanced Breast Cancer or Recurrent Ovarian Cancer;JAMA Oncology;2019-01-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3